Press Release

Symeres acquires Exemplify BioPharma, further strengthening its strategic foothold in the US

By WeAreBlowOctober 25, 2022No Comments

Previous PostKeensight Capital has reinforced its stake in Unither
Next PostKeensight Capital wins Best Corporate Sustainability Strategy at the Private Equity Wire ESG AAA European Awards 2022